Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
| NAV10/2/2024 | Chg.-0.4300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 214.3900EUR | -0.20% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 10/4/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 10/1/2024 | Prospectus | 2024 | German | 5,957.47 KB |
| 10/1/2024 | Prospectus | 2024 | English | 4,049.59 KB |
| 6/30/2024 | Semi-annual report | 2024 | German | 2,233.87 KB |
| 6/30/2024 | Semi-annual report | 2024 | English | 2,123.71 KB |
| 3/1/2024 | PRIIP Key Information Document | 2024 | German | 269.02 KB |
| 12/31/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 12/31/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 12/1/2022 | Key Investor Information | 2022 | German | 362.40 KB |
